Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo | Zendy

Hanhan Liu | Zendy; Fabian Anders | Zendy; Solon Thanos | Zendy; Carolina Mann | Zendy; Aiwei Liu | Zendy; Franz H. Grus | Zendy; Norbert Pfeiffer | Zendy; Verena ProkoschWilling | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo

Author(s) -

Hanhan Liu,

Fabian Anders,

Solon Thanos,

Carolina Mann,

Aiwei Liu,

Franz H. Grus,

Norbert Pfeiffer,

Verena ProkoschWilling

Publication year - 2017

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-22200

Subject(s) - optic nerve , retinal , retina , in vivo , glaucoma , chemistry , retinal ganglion cell , ophthalmology , pharmacology , medicine , biology , neuroscience , microbiology and biotechnology

Hydrogen sulfide (H2S) is recognized as a novel third signaling molecule and gaseous neurotransmitter. Recently, cell protective properties within the central nervous and cardiovascular system have been proposed. Our purpose was to analyze the expression and neuroprotective effects of H2S in experimental models of glaucoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research